IP Verse

Cyclodextrin - EP3022231

The patent EP3022231 was granted to Curadev Pharma PVT on Apr 18, 2018. The application was originally filed on Jul 16, 2014 under application number EP14742322A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3022231

CURADEV PHARMA PVT
Application Number
EP14742322A
Filing Date
Jul 16, 2014
Status
Granted And Under Opposition
Mar 16, 2018
Grant Date
Apr 18, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

LIGAND PHARMACEUTICALS INCORPORATEDJan 18, 2019HARRIS -

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTEP1950227
INTERNATIONAL-SEARCH-REPORTUS2009270348
INTERNATIONAL-SEARCH-REPORTWO2013123254
OPPOSITIONEP1950227
OPPOSITIONUS2009270348
OPPOSITIONUS2013303465
OPPOSITIONUS5134127
OPPOSITIONWO03092590
OPPOSITIONWO2013123254

Non-Patent Literature (NPL) Citations (8) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
INTERNATIONAL-SEARCH-REPORT- D. TYLER MCQUADE ET AL, "Applying Flow Chemistry: Methods, Materials, and Multistep Synthesis", THE JOURNAL OF ORGANIC CHEMISTRY, (20130705), vol. 78, no. 13, doi:10.1021/jo400583m, ISSN 0022-3263, pages 6384 - 6389, XP055142267 [Y] 1-19 * the whole document *
OPPOSITION- ZIA et al., "Thermodynamics of binding of neutral molecules to sulfobutyl ether beta-cyclodextrins (sbe-deta-cds):the effect of total degree of substitution", Pharmaceutical Research, (20000000), vol. 17, no. 8, pages 936 - 941, XP055577511-
OPPOSITION- HARTMAN Jensen et al., "Deciding Whether To Go with the Flow: Evaluating the Merits of Flow Reactors for Synthesis", Angew. Chem. Int. Ed., (20110000), vol. 50, pages 7502 - 7519, XP055577498
OPPOSITION- TAIT R. J. et al., "CHARACTERIZATION OF SULPHOALKYL ETHER DERIVATIVES OF BETA-CYCLODEXTRIN BY CAPILLARY ELECTROPHORESIS WITH INDIRECT UV DETECTION", J. Pharm. Biomed. Anal., (19920000), vol. 10, pages 615 - 622, XP000612110
OPPOSITION- BREWSTER et al., "Cyclodextrins as pharmaceutical solubilizers", Ad. Drug Del. Rev., (20070000), vol. 59, pages 645 - 666, XP002632015
OPPOSITION- GRARD et al., "Analysis of sulfobutyl ether beta -cyclodextrin mixtures by ion-spray mass spectrometry and liquid chromatography-ion-spray mass spectrometry", J. Chromatog A, (20010000), vol. 925, pages 79 - 87, XP004296300
OPPOSITION- D. TYLER MCQUADE et al., "Applying Flow Chemistry: Methods, Materials, and Multistep Synthesis", J. Org. Chem., (20130000), vol. 78, no. 13, pages 6384 - 6389, XP055142267
OPPOSITION- ZANNOU et al., "Osmotic Properties of Sulfobutylether and Hydroxypropyl Cyclodextrins", Pharmaceutical Research, (20010000), vol. 18, no. 8, pages 1226 - 1231, XP055184771

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents